Apogee Therapeutics: Citigroup Raises PT to $125 from $95, Maintains Buy Rating

martes, 24 de marzo de 2026, 11:35 am ET1 min de lectura
APGE--
C--

Apogee Therapeutics: Citigroup Raises PT to $125 from $95, Maintains Buy Rating

Apogee Therapeutics: Citigroup Raises PT to $125 from $95, Maintains Buy Rating

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios